Literature DB >> 24321208

Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials.

Caroline S Stokes1, Lise Lotte Gluud2, Markus Casper1, Frank Lammert3.   

Abstract

BACKGROUND & AIMS: The prevalence of gallstones is increasing in association with the obesity epidemic, but rapid weight loss also increases the risk of stone formation. We conducted a systematic review of the efficacy of strategies to prevent gallbladder stones in adults as they lose weight.
METHODS: Randomized controlled trials of nonsurgical strategies to prevent gallstones were identified by electronic and manual searches. Our final analysis included 13 trials, comprising 1836 participants undergoing weight loss through dieting (8 trials) or bariatric surgery (5 trials). The trials compared ursodeoxycholic acid (UDCA) or high-fat weight loss diets with control interventions. We performed random-effects meta-analyses and evaluated heterogeneity and bias with subgroup, sensitivity, regression, and sequential analysis.
RESULTS: UDCA reduced the risk of ultrasound-verified gallstones compared with control interventions (risk ratio, 0.33; 95% confidence interval [CI], 0.18-0.60; number needed to treat, 9). This effect was significantly larger in trials of diets alone (risk ratio, 0.17; 95% CI, 0.11-0.25) than in trials of patients who underwent bariatric surgery (risk ratio, 0.42; 95% CI, 0.21-0.83) (test for subgroup differences, P =.03). UDCA reduced the risk of cholecystectomy for symptomatic stones (risk ratio, 0.20; 95% CI, 0.07-0.53). Diets high in fat content also reduced gallstones, compared with those with low fat content (risk ratio, 0.09; 95% CI, 0.01-0.61). The meta-analyses were confirmed in trials with a low risk of bias but not in sequential analysis. No additional beneficial or harmful outcomes were identified.
CONCLUSIONS: On the basis of a meta-analysis of randomized controlled trials, during weight loss, UDCA and/or higher dietary fat content appear to prevent formation of gallstones.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric Surgery; Cholelithiasis; Cholesterol; Obesity

Mesh:

Substances:

Year:  2013        PMID: 24321208     DOI: 10.1016/j.cgh.2013.11.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  15 in total

1.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

2.  Global Variations in Practices Concerning Roux-en-Y Gastric Bypass-an Online Survey of 651 Bariatric and Metabolic Surgeons with Cumulative Experience of 158,335 Procedures.

Authors:  Parveen Kumar; Ho-Cing Victor Yau; Anand Trivedi; David Yong; Kamal Mahawar
Journal:  Obes Surg       Date:  2020-11       Impact factor: 4.129

3.  ABCG1 regulates mouse adipose tissue macrophage cholesterol levels and ratio of M1 to M2 cells in obesity and caloric restriction.

Authors:  Hao Wei; Elizabeth J Tarling; Timothy S McMillen; Chongren Tang; Renée C LeBoeuf
Journal:  J Lipid Res       Date:  2015-10-21       Impact factor: 5.922

4.  A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.

Authors:  Omar Pineda; Hernán G Maydón; Mónica Amado; Elisa M Sepúlveda; Lizbeth Guilbert; Omar Espinosa; Carlos Zerrweck
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

5.  Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice.

Authors:  Xiaoyun Feng; Cuiling Zhu; Sojin Lee; Jingyang Gao; Ping Zhu; Jun Yamauchi; Chenglin Pan; Sucha Singh; Shen Qu; Rita Miller; Satdarshan P Monga; Yongde Peng; H Henry Dong
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

6.  Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center.

Authors:  Shivanshu Misra; B Deepa Nandhini; S Christinajoice; S Saravana Kumar; S Prabhakaran; C Palanivelu; P Praveen Raj
Journal:  Obes Surg       Date:  2020-07-29       Impact factor: 4.129

7.  A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity.

Authors:  R Vilallonga; J L Pereira-Cunill; S Morales-Conde; I Alarcón; I Breton; E Domínguez-Adame; J V Ferrer; A Garcia Ruiz-de-Gordejuela; A Goday; A Lecube; E Martín García-Almenta; M Á Rubio; F J Tinahones; P P García-Luna
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

Review 8.  Excess Body Weight and Gallstone Disease.

Authors:  Caroline Sarah Stokes; Frank Lammert
Journal:  Visc Med       Date:  2021-06-15

9.  Roles of ursodeoxycholic acid in the bile biochemistry and metabolomics in patients with choledocholithiasis: a prospective study.

Authors:  Yaping Guan; Fei Xu; Xiaodong Zhang; Xiao Fu; Jing Wang; Sentao Song; Yan Sun; Qiongying Yuan; Feng Zhu
Journal:  Metabolomics       Date:  2022-07-01       Impact factor: 4.747

Review 10.  Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.

Authors:  Lukasz Kaska; Tomasz Sledzinski; Agnieszka Chomiczewska; Agnieszka Dettlaff-Pokora; Julian Swierczynski
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.